{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=70809L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=70809L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5201L,Language='FR')/Subjects"}},"ID":"5201","Language":"FR","MeetingNumber":11,"IdSession":5212,"SessionNumber":12,"SessionName":"Session de printemps 2026","Council":1,"CouncilName":"Conseil national","CouncilAbbreviation":"CN","Date":"\/Date(1773619200000)\/","Begin":"1430","Modified":"\/Date(1776247630025)\/","LegislativePeriodNumber":52,"PublicationStatus":"final","MeetingOrderText":"Onzi\u00e8me s\u00e9ance","SortOrder":11,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267242,IdSubject=70809L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267242,IdSubject=70809L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267242,IdSubject=70809L,Language='FR')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20267242,IdSubject=70809L,Language='FR')/Businesses"}},"IdSubject":"70809","BusinessNumber":20267242,"Language":"FR","BusinessShortNumber":"26.7242","Title":"Bonnes pratiques m\u00e9dicales","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1773416966513)\/","TitleDE":"Fragestunde.\nFrage Huber Alois.\nGood Medical Practice","TitleFR":"Heure des questions.\nQuestion Huber Alois.\nBonnes pratiques m\u00e9dicales","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=371763L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371763L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371763L,Language='FR')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371763L,Language='FR')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=371763L,Language='FR')/Businesses"}},"ID":"371763","Language":"FR","IdSubject":"70809","VoteId":null,"PersonNumber":4238,"Type":1,"Text":"<pd_text><p>Die Covid-19-Impfstoffe wurden w\u00e4hrend der Entwicklung umfassend getestet und von Swissmedic sorgf\u00e4ltig gepr\u00fcft. Zugelassen werden nur Impfstoffe, die sicher, wirksam und qualitativ hochwertig sind. Auch nach der Zulassung erfolgen regelm\u00e4ssige Kontrollen. F\u00fcr mRNA-Impfstoffe gelten sehr konservative Grenzwerte f\u00fcr Verunreinigungen; dies gilt insbesondere auch f\u00fcr Rest-DNA. Jede Impfstoffcharge wird in der Schweiz und in der EU vor der Auslieferung beh\u00f6rdlich gepr\u00fcft. Dieses Vorgehen entspricht den \u00fcblichen wissenschaftlichen und regulatorischen Standards. Umfangreiche Daten aus \u00fcber f\u00fcnf Jahren best\u00e4tigen die Qualit\u00e4t, Sicherheit und Wirksamkeit der mRNA-Impfstoffe. Alle internationalen und nationalen Anforderungen sind erf\u00fcllt, weshalb der Bundesrat keinen Anlass sieht, die Zulassung dieser Impfstoffe auszusetzen.</p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20260316","MeetingVerbalixOid":4144,"IdSession":"5212","SpeakerFirstName":"Elisabeth","SpeakerLastName":"Baume-Schneider","SpeakerFullName":"Baume-Schneider Elisabeth","SpeakerFunction":"BR-F","CouncilId":99,"CouncilName":"Conseil f\u00e9d\u00e9ral","CantonId":26,"CantonName":"Jura","CantonAbbreviation":"JU","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1773673844588)\/","End":"\/Date(1773673907316)\/","Function":"BR-F","DisplaySpeaker":true,"LanguageOfText":"DE","Modified":"\/Date(1790250099417)\/","StartTimeWithTimezone":"\/Date(1773673844587+0060)\/","EndTimeWithTimezone":"\/Date(1773673907317+0060)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"70809","Language":"FR","IdMeeting":"5201","VerbalixOid":796905,"SortOrder":26,"Modified":"\/Date(1790250099411)\/"}}